<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27828648</article-id>
      <article-id pub-id-type="pmc">5087233</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164181</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Henoch-Sch&#xF6;nlein purpura with c-ANCA antibody in an adult<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Torraca</surname>
            <given-names>Pedro de Freitas Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Castro</surname>
            <given-names>Bruna Corr&#xEA;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hans Filho</surname>
            <given-names>G&#xFC;nter</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Universidade Federal de Mato Grosso do Sul (UFMS) &#x2013;
Campo Grande (MS), Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Mailing address: Pedro de Freitas Silva Torraca, Av. Senador
Filinto M&#xFC;ller, 1 Pioneiros, 79080-190 - Campo Grande - MS Brazil.
E-mail: <email>pftorraca@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>5</issue>
      <fpage>667</fpage>
      <lpage>669</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>2</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The Henoch-Sch&#xF6;nlein purpura is the vasculitis associated with deposits of
immunoglobulin A in small vessels. Its association with cytoplasmic
antineutrophil cytoplasmic antibodies is possible, but rare. This vasculitis is
uncommon in adults and the main clinic manifestations are purpuric lesions in
lower limbs with gastrointestinal symptoms and renal involvement. The present
work describes a rare case of Henoch-Sch&#xF6;nlein purpura in an adult with
cytoplasmic antineutrophil cytoplasmic antibodies.</p>
      </abstract>
      <kwd-group>
        <kwd>Antibodies, antineutrophil cytoplasmic</kwd>
        <kwd>Purpura, Schoenlein-Henoch</kwd>
        <kwd>Vasculitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Henoch-Sch&#xF6;nlein purpura (HSP), purpura rheumatica or anaphylactoid purpura,
currently named IgA vasculitis, is a systemic vasculitis of small vessels, mediated
by immunocomplexes.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Although it
typically affects children, there are reports of onset in adults.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> Classically, the clinical picture is
characterized by skin involvement (palpable purpura or petechial lesions in 100% of
cases), arthralgia, abdominal pain and nephropathy.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup>
Histopathology of skin demonstrates leukocytoclastic vasculitis associated with
deposition of IgA on vessels.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> As
opposed to other vasculitides, such as granulomatous polyangiitis (Wegener's),
microscopic polyangiitis and Churg-Strauss syndrome, positive markers for c-ANCA,
class of cytoplasmic antineutrophil cytoplasmic antibodies, are rarely found in
HSP.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male patient, 22 years old, complained about skin lesions, abdominal pain and
polyarthralgia for the previous three days, after using a high-protein food
supplement. At the dermatological examination, papular and macular
erythematous-purpuric lesions and some target lesions with hemorrhagic-content
bullae, located on the extensor surface of the upper limbs, on the back, buttocks
and lower limbs in a symmetric fashion were observed (<xref ref-type="fig" rid="f1">Figure 1</xref>, <xref ref-type="fig" rid="f2">2</xref> and <xref ref-type="fig" rid="f3">3</xref>). At the physical examination, edema was
noticed in the knees, elbows and shoulders.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Papular and erythematous-purpuric lesions on the back and upper limbs</p>
          </caption>
          <graphic xlink:href="abd-91-05-0667-g01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Erythematous-purpuric macules and papules in the posterior region of
lower limbs, besides target lesions and hemorrhagic bullae</p>
          </caption>
          <graphic xlink:href="abd-91-05-0667-g02"/>
        </fig>
      </p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Detail of lesions on lower limb</p>
          </caption>
          <graphic xlink:href="abd-91-05-0667-g03"/>
        </fig>
      </p>
      <p>Laboratory tests showed normocytic and normochromic anemia, creatinine 3.50 mg/dl,
TMSI with microscopic hematuria, proteinuria of 3.18 g per 24 hours, complement
consumption, increased polyclonal gamma globulins, besides c-ANCA positivity with
titers of 1:640 in two samples. Markers for hepatic function and lesion did not
exhibit changes, serologies for hepatitis, syphilis and HIV were negative, tests for
p-ANCA and ANF were non-reagent, coagulogram and x-ray of thorax and sinuses were
normal.</p>
      <p>Histopathology of skin revealed fibrinoid necrosis and neutrophilic infiltrate with
leukocytoclasia in small vessels of the superficial dermis (<xref ref-type="fig" rid="f4">Figure 4</xref>). Direct immunofluorescence revealed granular deposits
of IgA in the walls of vessels in the papillary and middle dermis (<xref ref-type="fig" rid="f5">Figure 5</xref>). Treatment was done with prednisone (1
mg/kg/day) and cyclophosphamide (20 mg/kg, single dose).</p>
      <p>
        <fig id="f4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Histological examination of skin demonstrating fibrinoid necrosis and
neutrophilic infiltrate with leukocytoclasia in small vessels of
superficial dermis (HE, 100x)</p>
          </caption>
          <graphic xlink:href="abd-91-05-0667-g04"/>
        </fig>
      </p>
      <p>
        <fig id="f5" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Granular deposits of IgA in vessels of superficial dermis under direct
immunofluorescence</p>
          </caption>
          <graphic xlink:href="abd-91-05-0667-g05"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>HSP is a neutrophilic vasculitis of small vessels, resulting from intravascular
deposition of IgA complexes.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> It is
the most common vasculitis in children, affecting preferably males, with an
incidence peak between 2 and 11 years of age (75% of the cases) and self-limited
course most of the times.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> It is
characterized by the presence of the tetrad formed by non-thrombocytopenic palpable
purpura, arthralgia, abdominal pain and renal changes.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>More than 90% of the reported HSP cases occurred in individuals up to 12 years old.4
Although rare, cases in adults have already been described in a worldwide incidence
varying from 3.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> and 14.3 cases per
1 million inhabitants.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup> HSP typically appears after an acute infectious event, but may
arise from direct contact with chemical products or food allergens, such as milk or
gluten proteins.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>Diagnostic criteria for HSP include palpable purpura on lower limbs as a mandatory
criterion and the presence of at least one of the following lesser criteria: diffuse
abdominal pain, arthritis or arthralgia, hematuria or proteinuria and vascular
deposits of IgA, revealed by direct immunofluorescence.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> These deposits are responsible for renal changes,
initially with pure mesangial proliferative glomerulonephritis and later evolving to
membranoproliferative glomerulonephritis and renal failure.<sup><xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup> In histopathology, we observed leukocytoclastic vasculitis of
arterioles and venules of affected sites.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> Although typical target lesions suggest the diagnosis of
multiform erythema, clinical-laboratorial findings help in diagnostic
definition.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>Among the main differential diagnoses of HSP are multiform erythema and
granulomatosis with polyangiitis. Even though clinically similar in some cases, HSP
originally does not present a profile of neutrophil cytoplasmic antibodies, like in
granulomatosis with polyangiitis, or Wegener's granulomatosis.<sup><xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> These antibodies are associated with necrotizing
vasculitides and are classified according to its target antigen in two patterns: the
specific pattern for myeloperoxidase (MPO-ANCA) of perinuclear presentation
(p-ANCA), and the specific standard for proteinase 3 (PR3-ANCA), of cytoplasmic
presentation (c-ANCA).<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup> Commonly the c-ANCA antibody is an IgG immunoglobulin, but it
may be of type IgA or IgM.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> The
lack of involvement of the respiratory tract and evidence of granulomatous
infiltration - characteristic presentations of necrotizing vasculitides - reinforces
the diagnosis of HSP with positive c-ANCA.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>Even with self-limiting symptoms most of the times, some cases of HSP require drug
treatment.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> This
recommendation depends mainly on the presence of renal involvement, because 5% of
nephropathies are severe and may progress to renal failure. Some reports link c-ANCA
positivity with fulminating nephropathy by deposits of IgA in a limited renal form
of HSP.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> Therefore, this
association may require more aggressive therapeutic measures, with the use of
immunosuppressors. Corticosteroids are indicated when development of
glomerulonephritis is suspected or when there is abdominal pain or intense
arthralgia.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> The association of corticosteroids
with azathioprine is indicated for treatment of glomerulonephritis already in
course, and the association of corticosteroid with cyclophosphamide is considered in
rapidly progressive glomerulonephritis. Colchicine may be used to control extensive
skin lesions. For cases that are refractory to immunosuppressive treatment, the use
of intravenous immunoglobulin is an alternative.<sup><xref rid="r2" ref-type="bibr">2</xref></sup></p>
      <p>From 2013, the American College of Rheumatology, the American Society of Nephrology
and the European League Against Rheumatism (EULAR) renamed HSP as IgA Vasculitis,
taking into consideration the deposits of immunoglobulin on small vessels, observed
in the pathogenesis of vasculitis.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at Hospital Universit&#xE1;rio Maria Aparecida Pedrossian, of
Universidade Federal de Mato Grosso do Sul (Humap-UFMS) &#x2013; Campo Grande (MS),
Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jennette</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bacon</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cid</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ferrario</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2012 Revised International Chapel Hill Consensus Conference
Nomenclature of Vasculitides</article-title>
          <source>Arthritis Rheum</source>
          <year>2013</year>
          <volume>65</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">23045170</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jithpratuck</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Elshenawy</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saleh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Youngberg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Krishnaswamy</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>The clinical implications of adult-onset Henoch-Schoenlein
purpura</article-title>
          <source>Clin Mol Allergy</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>9</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">21619657</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Arnone</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sotto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Vasculite cut&#xE2;nea de pequenos vasos: subtipos e
tratamento - Parte I</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>387</fpage>
          <lpage>406</lpage>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Arnone</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sotto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Vasculite cut&#xE2;nea de pequenos vasos: subtipos e
tratamento - Parte II</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>499</fpage>
          <lpage>511</lpage>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alfredo</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Len</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Terreri</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Hil&#xE1;rio</surname>
              <given-names>MO</given-names>
            </name>
          </person-group>
          <article-title>Henoch-Sch&#xF6;nlein purpura: recurrence and
chronicity</article-title>
          <source>J Pediatr (Rio J)</source>
          <year>2007</year>
          <volume>83</volume>
          <fpage>177</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">17327931</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boulis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Majithia</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>McMurray</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Adult-onset Henoch-Schonlein purpura with positive c-ANCA
(anti-proteinase 3): Case report and review of literature</article-title>
          <source>Rheumatol Int</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>493</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">20963420</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Positive c-ANCA in Henoch-Schonlein purpura: what is the
mechanism?</article-title>
          <source>Comment on: Adult-onset Henoch-Schonlein purpura with positive c-ANCA
(anti-proteinase 3): case report and review of literature Rheumatol
Int</source>
          <year>2014</year>
          <volume>34</volume>
          <fpage>1017</fpage>
          <lpage>1017</lpage>
          <pub-id pub-id-type="pmid">23893034</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Almeida</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Paim</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Leone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Renal involvement in Henoch-Sch&#xF6;nlein purpura: a
multivariate analysis of initial prognostic factors</article-title>
          <source>J Pediatr (Rio J)</source>
          <year>2007</year>
          <volume>83</volume>
          <fpage>259</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="pmid">17551657</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Jennette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <chapter-title>IgA Nephropathy and IgA Vasculitis (Henoch-Sch&#xF6;nlein
Purpura)</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Fogo</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Colvin</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Jennette</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Alpers</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <source>Fundamentals of Renal Pathology</source>
          <year>2014</year>
          <publisher-loc>New Yok</publisher-loc>
          <publisher-name>Springer Berlin Heidelberg</publisher-name>
          <fpage>69</fpage>
          <lpage>78</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Ciorba</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>Significance of antineutrophil cytoplasmic antibody in adult
patients with Henoch-Sch&#xF6;nlein purpura presenting mainly with
gastrointestinal symptoms</article-title>
          <source>World J Gastroenterol</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>622</fpage>
          <lpage>626</lpage>
          <pub-id pub-id-type="pmid">18203298</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
